Patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation have favorable long-term outcome irrespective of their genetic background | Zendy

Jiří Bonaventura | Zendy; Patricia Norambuena | Zendy; Pavel Votýpka | Zendy; Hana Hnátová | Zendy; Radka Adlová | Zendy; Milan Maçek | Zendy; Josef Veselka | Zendy

Open Access

Patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation have favorable long-term outcome irrespective of their genetic background

Author(s) -

Jiří Bonaventura,

Patricia Norambuena,

Pavel Votýpka,

Hana Hnátová,

Radka Adlová,

Milan Maçek,

Josef Veselka

Publication year - 2020

Publication title -

cardiovascular diagnosis and therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.83

H-Index - 22

eISSN - 2223-3660

pISSN - 2223-3652

DOI - 10.21037/cdt.2020.01.12

Subject(s) - medicine , alcohol septal ablation , hypertrophic cardiomyopathy , cardiology , ventricular outflow tract , ventricular outflow tract obstruction , interventricular septum , cardiomyopathy , mortality rate , gastroenterology , heart failure , obstructive cardiomyopathy , ventricle

The genetic background of patients with hypertrophic cardiomyopathy (HCM) treated with alcohol septal ablation (ASA) and its relationship to the outcomes are not known. We aimed to investigate whether the outcome of genotype positive (G+) patients differs from genotype negative (G-) patients treated with ASA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research